Diagnostic Performance of Nanoparticle-Enhanced Magnetic Resonance Imaging in the Diagnosis of Lymph Node Metastases in Patients With Endometrial and Cervical Cancer
Top Cited Papers
- 20 April 2005
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (12) , 2813-2821
- https://doi.org/10.1200/jco.2005.07.166
Abstract
Purpose Lymph node metastases affect management and prognosis of patients with gynecologic malignancies. Preoperative nodal assessment with computed tomography or magnetic resonance imaging (MRI) is inaccurate. A new lymph node–specific contrast agent, ferumoxtran-10, composed of ultrasmall particles of iron oxide (USPIO), may enhance the detection of lymph node metastases independent of node size. Our aim was to compare the diagnostic performance of MRI with USPIO against standard size criteria. Methods Forty-four patients with endometrial (n = 15) or cervical (n = 29) cancer were included. MRI was performed before and after administration of USPIO. Two independent observers viewed the MR images before lymph node sampling. Lymph node metastases were predicted using size criteria and USPIO criteria. Lymph node sampling was performed in all patients. Results Lymph node sampling provided 768 pelvic or para-aortic nodes for pathology, of which 335 were correlated on MRI; 17 malignant nodes were found in 11 of 44 patients (25%). On a node-by-node basis, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) by size criteria were 29%*, 99%, 56%, and 96%, and by USPIO criteria (reader 1/reader 2) were 93%/82%* (*P = .008/.004), 97%/97%, 61%/59%, and 100%/99%, respectively (where [*] indicates the statistical difference of P = x/x between the two results marked by the asterisk). On a patient-by-patient basis, sensitivity, specificity, PPV, and NPV by size criteria were 27%*, 94%, 60%, and 79%, and by USPIO criteria (reader 1/reader 2) were 100%/91%* (*P = .031/.06), 94%/87%, 82%/71%, and 100%/96%, respectively. The κ statistic was 0.93. Conclusion Lymph node characterization with USPIO increases the sensitivity of MRI in the prediction of lymph node metastases, with no loss of specificity. This may greatly improve preoperative treatment planning.Keywords
This publication has 22 references indexed in Scilit:
- Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic reviewGynecologic Oncology, 2003
- Port site metastasis after laparoscopy for uterine cervical carcinomaSurgical Endoscopy, 2003
- Laparoscopic Staging Compared with Imaging Techniques in the Staging of Advanced Cervical CancerGynecologic Oncology, 2002
- Laparoscopic Retroperitoneal Lymphadenectomy Followed by Immediate Laparotomy in Women with Cervical Cancer: A Gynecologic Oncology Group StudyGynecologic Oncology, 2002
- Metastatic Lymph Nodes in Patients with Cervical Cancer: Detection with MR Imaging and FDG PETRadiology, 2001
- Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging.American Journal of Roentgenology, 1998
- Adenocarcinoma of the uterine cervix metastatic to lymph nodesAmerican Journal of Obstetrics and Gynecology, 1998
- Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the gynecologic oncology groupCancer, 1991
- Revised FIGO staging for gynaecological cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- The significance of paraaortic node status in carcinoma of the cervix and endometriumGynecologic Oncology, 1986